secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001193805-25-000820
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus shareholders elect all 9 director nominees, approve say-on-pay, ratify Deloitte
--------------------------------------------------------------------------------

- All nine director nominees elected; votes ranged from 18,555,174 (Dr. Holmes) to 19,059,965 (Dr. Slaoui).
- Say-on-pay resolution approved: 18,472,131 for, 586,006 against, 64,724 abstain, 2,883,662 broker non-votes.
- Ratification of Deloitte & Touche as FY2025 auditor passed: 21,971,168 for, 30,589 against, 4,767 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380525000820/0001193805-25-000820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380525000820/e664613_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-25-000820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer